(Bloomberg) -- As earnings season gathers pace, a slew of weak results and a hawkish European Central Bank risk spoiling the rally that spurred European equities to their best-ever start to a year. Most Read from BloombergAdani Rout Hits $68 Billion as Fight With Hindenburg IntensifiesAdani Tries to Calm Investors With 413-Page Hindenburg RebuttalWall Street Is Losing Out to Amateur Buyers in the Housing SlumpHistoric Crash for Memory Chips Threatens to Wipe Out EarningsRussia Can’t Replace the
By Geoffrey Smith
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.